Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | SRI SAI AGENCIESLikely | RA Ended | 9 | ₹840 |
| 2 | Schedule 2 | SRI SAI AGENCIESLikely | RA Ended | 11 | ₹1,871.70 |
| 3 | Schedule 3 | arihant pharma | Awarded | 1 | ₹1,684.50 |
| 4 | Schedule 4 | JAIN PHARMALikely | RA Ended | 11 | ₹10,205 |
| 5 | Schedule 5 | GAUTAM AGENCIESLikely | RA Ended | 11 | ₹5,145 |
Tender Value
₹1.1 L
EMD Value
Exempted
Closing Date
20 Jan 2026, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Cinnarizine 25 mg Tab
Betahistine Dihydro Chloride 8mg Tab
Ketorolac Tromethamine 0 point 4 percentage Eye Drop
Nasal Decongestant Adult Drops Xylometazoline Hcl 0 point 1percentage W V Nasal Drop Bott of 10ml
Xylometazoline HCl 0 point 05 percentage w v nasal solution for paed use bott of 10ml
Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab
Gentamycin sulphate Inj IM IV 40mg ml
2 ml Inj
Inj Benzathine penicillin IP 6
00
000 IU
Amoxycillin for oral susp containing Amoxycillin base 125mg per 5 ml after reconstitution bottle of 30 ml
Atropine Sulphate 0 point6 mg
1 ml Inj
Diclofenac 25 mg ml IP
3 ml Inj
Chlorhexidine Solution containing Chlorhexidine Gluconate BP 7 point 5 percentage v v Cetrimide BP 15 percentage
8755933
GEM/2025/B/7038385
Two Packet Bid
Cinnarizine 25 mg Tab
30 days
West Bengal; Kolkata
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹31
₹1 L
20%
Exempted
20 Jan 2026
30 Dec 2025
20 Jan 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Cinnarizine 25 mg Tab | Cinnarizine 25 mg Tab | 2,800 | No | Kolkata | 30 |
| 2 | Betahistine Dihydro Chloride 8mg Tab | Betahistine Dihydro Chloride 8mg Tab | 5,505 | No | Kolkata | 30 |
| 3 | Ketorolac Tromethamine 0 point 4 percentage Eye Drop | Ketorolac Tromethamine 0.4% Eye Drop | 150 | Bott | Kolkata | 30 |
| 4 | Nasal Decongestant Adult Drops Xylometazoline Hcl 0 point 1percentage W V Nasal Drop Bott of 10ml | Nasal Decongestant Adult Drops (Xylometazoline Hcl 0.1% W/V Nasal Drop) Bott of 10ml. | 1,300 | Bott | Kolkata | 30 |
| 5 | Xylometazoline HCl 0 point 05 percentage w v nasal solution for paed use bott of 10ml | Xylometazoline HCl 0.05% w/v nasal solution for paed use bott of 10ml | 700 | Bott | Kolkata | 30 |
| 6 | Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab | Sulphamethoxazole 400 mg & Trimethoprim 80 mg Tab | 7,500 | No | Kolkata | 30 |
| 7 | Gentamycin sulphate Inj IM IV 40mg ml, 2 ml Inj | Gentamycin sulphate Inj IM/IV 40mg/ml, 2 ml Inj | 2,400 | Amp | Kolkata | 30 |
| 8 | Inj Benzathine penicillin IP 6,00,000 IU | Inj Benzathine penicillin I.P 6,00,000 I.U | 90 | AMP or VIAL | Kolkata | 30 |
| 9 | Amoxycillin for oral susp containing Amoxycillin base 125mg per 5 ml after reconstitution bottle of 30 ml | Amoxycillin for oral susp containing Amoxycillin base 125mg per 5 ml after reconstitution (bottle of 30 ml) | 800 | Bott | Kolkata | 30 |
| 10 | Atropine Sulphate 0 point6 mg, 1 ml Inj | Atropine Sulphate 0.6 mg, 1 ml Inj | 1,400 | Amp | Kolkata | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8755933.pdf
GEM_BID
origin396_2025-12-24-09-05-44_d207767521196ce156090728af736ed9.pdf
BOQ
boq_item_sample_file_396_2025-12-24-09-05-44_34365e7f0ff08d9d6bc33d34df25bfd5.csv
BOQ
Origin396_904f7029-2497-491b-9c791766548326486_buyer13chec.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .